With the investigational BrainGate system, a sensor implanted in the part of the brain that controls motion allows paralyzed patients to control a robot arm by thought.
Thanks to the work of Drs. Alice Shaw and Jeff Engelman, important discoveries are being made about ALK-positive non-small-cell lung cancer at Mass General.
In the face of a growing heroin epidemic, MGH psychologist John Kelly, PhD, strives to provide easy access to science-based information about recovery.
The Mass General Cardio Oncology Program is designed to coordinate care for cancer patients and cancer survivors who have heart disease or are at risk of developing it.
Susan A. Slaugenhaupt, PhD, is exploring how her research on familial dysautonomia, a rare disease, might provide important insights about other disorders.
Basic science and creative research benefit from the MGH Research Scholars Program, says Jack Szostak, PhD, a renowned MGH scientist and Nobel Laureate.
Raul Mostoslavsky, MD, PhD, and his Mass General team have identified a protein that puts the brakes on cancer cell growth by regulating certain genes.
Sekar Kathiresan, MD, is determined to better understand the genes linked to heart attacks and how they contribute to the development of heart disease.
Mass General researchers have created a new generation of brain mapping images that promises to open the door to understanding and treating brain disorders.
With the goal of detecting and treating Alzheimer’s disease before symptoms appear, researchers at Mass General have teamed up with an army of volunteers.